Compare EXLS & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXLS | NOVT |
|---|---|---|
| Founded | 1999 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.0B |
| IPO Year | 2004 | 1999 |
| Metric | EXLS | NOVT |
|---|---|---|
| Price | $34.87 | $168.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $46.80 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 2.6M | 444.8K |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.27 | N/A |
| EPS | 0.43 | ★ 0.82 |
| Revenue | N/A | ★ $521,290,000.00 |
| Revenue This Year | $12.61 | $8.61 |
| Revenue Next Year | $10.55 | $6.57 |
| P/E Ratio | ★ $80.60 | $199.17 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $24.85 | $98.27 |
| 52 Week High | $45.04 | $176.38 |
| Indicator | EXLS | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 67.64 | 62.25 |
| Support Level | $28.95 | $146.45 |
| Resistance Level | $36.27 | $167.79 |
| Average True Range (ATR) | 1.51 | 6.87 |
| MACD | 0.58 | 2.29 |
| Stochastic Oscillator | 83.96 | 67.75 |
ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.